Comments on: Clarinex Patent Fight Nothing To Sneeze At http://www.pharmalot.com/2008/04/clarinex-patent-fight-nothing-to-sneeze-at/ News, Comment and Conversation Sun, 06 Jul 2008 00:43:52 +0000 http://wordpress.org/?v=2.5.1 By: the condor http://www.pharmalot.com/2008/04/clarinex-patent-fight-nothing-to-sneeze-at/#comment-328526 the condor Thu, 01 May 2008 22:56:04 +0000 http://www.pharmalot.com/?p=13388#comment-328526 UPDATED! McCarter & English, LLP has filed <a href="http://shearlingsplowed.blogspot.com/2008/05/hmmm-does-ashley-work-for-mccarter-and.html" rel="nofollow">Schering's Response in the above case</a>, tonight -- May 1, 2008. I've got the goods on it -- and, to cut to the chase, here: I remain unconvinced that Schering has a case. IMO, Orchid sure seems to have a good one. So, I think Orchid is going to be able to launch in mid- to late-2008. Take a look: http://shearlingsplowed.blogspot.com/2008/05/hmmm-does-ashley-work-for-mccarter-and.html UPDATED!

McCarter & English, LLP has filed Schering’s Response in the above case, tonight — May 1, 2008. I’ve got the goods on it — and, to cut to the chase, here: I remain unconvinced that Schering has a case.

IMO, Orchid sure seems to have a good one.

So, I think Orchid is going to be able to launch in mid- to late-2008.

Take a look:

http://shearlingsplowed.blogspot.com/2008/05/hmmm-does-ashley-work-for-mccarter-and.html

]]> By: Prescription Access Litigation (PAL) Project » Blog Archive » What’s a “Goober Grape” drug? Just ask Schering-Plough & Merck… http://www.pharmalot.com/2008/04/clarinex-patent-fight-nothing-to-sneeze-at/#comment-324148 Prescription Access Litigation (PAL) Project » Blog Archive » What’s a “Goober Grape” drug? Just ask Schering-Plough & Merck… Wed, 30 Apr 2008 17:37:34 +0000 http://www.pharmalot.com/?p=13388#comment-324148 [...] Combination drugs like these are intended to serve one purpose: to increase the manufacturers’ market share, particularly in the face of impending generic competition. Schering-Plough has been down a road like this already with Claritin — when Claritin was set to go generic, they introduced Clarinex. Clarinex (desloratidine) is simply a metabolite of Claritin (loratidine) — in a nutshell, Clarinex is what Claritin becomes in your liver. As one blogger put it, “if you’ve taken Claritin, you’ve taken Clarinex.” Thankfully, doctors and patients weren’t really fooled, and sales of Clarinex were never very impressive. I stand corrected! According to this item on Pharmalot, 2007 sales of Clarinex were $799 million! (See “Clarinex Patent Fight Nothing To Sneeze At“) [...] [...] Combination drugs like these are intended to serve one purpose: to increase the manufacturers’ market share, particularly in the face of impending generic competition. Schering-Plough has been down a road like this already with Claritin — when Claritin was set to go generic, they introduced Clarinex. Clarinex (desloratidine) is simply a metabolite of Claritin (loratidine) — in a nutshell, Clarinex is what Claritin becomes in your liver. As one blogger put it, “if you’ve taken Claritin, you’ve taken Clarinex.” Thankfully, doctors and patients weren’t really fooled, and sales of Clarinex were never very impressive. I stand corrected! According to this item on Pharmalot, 2007 sales of Clarinex were $799 million! (See “Clarinex Patent Fight Nothing To Sneeze At“) [...]

]]>